Individual generic drug information

olopatadine

Reference monograph

Part of registered formulation

OLOPATADINE HYDROCHLORIDE

Reference record: Olopatadine
Source: BNF 80 (2020–2021)
Printed source pages: 1246
Age groups indexed: 2

Individual active ingredientSource records are displayed separately

Some source sections could not be separated reliably in the extraction. Review the printed source pages when a field is missing or incomplete.

Overview

Extracted information for Olopatadine only.

Indications And Dose

Seasonal allergic conjunctivitis ▶TO THE EYE ▶Child 3–17 years: Apply twice daily for maximum 4 months ▶Adult: Apply twice daily for maximum 4 months

Source page 1246

Safety

Extracted information for Olopatadine only.

Side Effects

▶Common or very common Asthenia. dry eye. eye discomfort. headache. nasal dryness. taste altered Eye ▶Uncommon Dizziness. eye disorders. eye inﬂammation. increased risk of infection. numbness. skin reactions. vision disorders ▶Frequency not known Drowsiness. dyspnoea. malaise. nausea. vomiting

Source page 1246

Dose and formulations

Extracted information for Olopatadine only.

Medicinal Forms

There can be variation in the licensing of different medicines containing the same drug. Eye drops EXCIPIENTS: May contain Benzalkonium chloride ▶Olopatadine (Non-proprietary) Olopatadine (as Olopatadine hydrochloride) 1 mg per 1 ml Olopatadine 1mg/ml eye drops | 5 ml P £6.14 DT = £4.68 ▶Opatanol (Novartis Pharmaceuticals UK Ltd) Olopatadine (as Olopatadine hydrochloride) 1 mg per 1 ml Opatanol 1mg/ml eye drops | 5 ml P £4.68 DT = £4.68 MAST-CELL STABILISERS

Source page 1246

Dose text by age group

Filter the extracted dose blocks for this individual drug.

Children

First line only; read the complete Indications and dose section above.

Apply twice daily for maximum

This is a first-line fragment. Read the full Indications and Dose section above.

Candidate age grouping · source page 1246

Adults

First line only; read the complete Indications and dose section above.

Apply twice daily for maximum 4 months

This is a first-line fragment. Read the full Indications and Dose section above.

Candidate age grouping · source page 1246

Age labels are extracted from the printed dose headings and require clinical review. Confirm current local guidance, dose, route, formulation, contraindications and interactions before prescribing.

Individual generic drug information

olopatadine

Reference monograph

Part of registered formulation

OLOPATADINE HYDROCHLORIDE

Reference record: Olopatadine
Source: BNF 80 (2020–2021)
Printed source pages: 1246
Age groups indexed: 2

Individual active ingredientSource records are displayed separately

Some source sections could not be separated reliably in the extraction. Review the printed source pages when a field is missing or incomplete.

Overview

Extracted information for Olopatadine only.

Indications And Dose

Seasonal allergic conjunctivitis ▶TO THE EYE ▶Child 3–17 years: Apply twice daily for maximum 4 months ▶Adult: Apply twice daily for maximum 4 months

Source page 1246

Safety

Extracted information for Olopatadine only.

Side Effects

Source page 1246

Dose and formulations

Extracted information for Olopatadine only.

Medicinal Forms

Source page 1246

Dose text by age group

Filter the extracted dose blocks for this individual drug.

Children

First line only; read the complete Indications and dose section above.

Apply twice daily for maximum

This is a first-line fragment. Read the full Indications and Dose section above.

Candidate age grouping · source page 1246

Adults

First line only; read the complete Indications and dose section above.

Apply twice daily for maximum 4 months

This is a first-line fragment. Read the full Indications and Dose section above.

Candidate age grouping · source page 1246

Age labels are extracted from the printed dose headings and require clinical review. Confirm current local guidance, dose, route, formulation, contraindications and interactions before prescribing.